Intended Audience:
This program is intended for interventional cardiologists, as well as physician specialists who manage patients in the emergency department, coronary care unit, and cardiac catheterization laboratory.
Grantor Support:
Supported by an independent educational grant from The Medicines Company, Inc.
Registration:
Enrollment for this course is complimentary, and clinicians are invited to attend this CME-certified symposium and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.
Accreditation Statement for Jointly-Sponsored Programs:
This activity has been planned and implemented in accordance with the Essential
Areas and Policies of the Accreditation Council for Continuing Medical Education
through the joint sponsorship of The University of Massachusetts Medical School
and CMEducation Resources, LLC. The University of Massachusetts Medical School
is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement:
The University of Massachusetts Medical School designates this educational activity
for a maximum of 3 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit
commensurate with the extent of their participation in the activity.
Policy on Faculty and Provider Disclosure:
It is the policy of the University of Massachusetts Medical School to ensure fair
balance, independence, objectivity and scientific rigor in all activities. All
faculty participating in CME activities sponsored by the University of Massachusetts
Medical School are required to present evidence-based data, identify and reference
off-label product use and disclose all relevant financial relationships with those
supporting the activity or others whose products or services are discussed. Faculty
disclosure will be provided in the activity materials
Faculty Disclosures:
Frederick Feit, MD
Consultant: The Medicines Company
Steven Manoukian, MD
Consultant: The Medicines Company
Speaker’s Bureau: The Medicines Company
Gary L. Shaer, MD
Consultant: sanofi-aventis
Speaker's Bureau: sanofi-aventis, The Medicine Company
Charles Pollack, MD, FACEP
Consultant: The Medicines Company
Speaker’s Bureau: sanofi-aventis, Schering-Plough Corporation
Educational Objectives:
-
As a result of this session, cardiologists will be able to assess and
implement optimal antithrombotic strategies for patients with NSTEMI and STEMI.
-
As a result of this session, attendees will understand impact of specific
pharmacologic agents on outcomes, including ischemic endpoints, bleeding,
and mortality for patients with ACS.
-
As a result of this session, attendees are able to discuss the impact that new
trials are likely to have on future management of patients with ACS who
require an invasive strategy
-
As a result of this session, physicians will learn to apply AHA/ACC and
other national guidelines in order to optimize therapy of patients with ACS
-
Clinicians will learn about the safety and efficacy of various antithrombotic
agents and their use across subgroups of patients undergoing PCI
-
Clinicians will learn abut the central role of bleeding minimization
and transfusion reduction/avoidance in patients undergoing PCI
-
Clinicians will learn how to apply multiple clinical trials designed
to evaluate ischemic risk and hemorrhagic risks in ACS patients undergoing PCI
Distinguished Program Faculty and Panel Members
Steven V.
Manoukian
, M.D., F.A.C.C.
(Program Chairman)
Director, Interventional Cardiology
Emory Crawford Long Hospital
Associate Professor
Department of Cardiology
Emory University School of Medicine
Atlanta, Georgia
Frederick
Feit
, MD, FACC
Director, Cardiac Catheterization & Interventional Cardiology
Bellevue Hospital Center
Associate Professor of Medicine
New York University School of Medicine
New York, NY
Gary L.
Schaer
, M.D., F.A.C.C.
Professor of Medicine
Director, Cardiac Cath Labs
Rush University Medical Center
Chicago, IL
Charles V.
Pollack
, Jr, MA, MD,FACEP
Chairman, Department of Emergency Medicine
Pennsylvania Hospital
Associate Professor of Emergency Medicine
University of Pennsylvania
School of Medicine
Philadelphia, PA
Copyright (c) 2006 All rights reserved including
